An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients
Authors:
- 24 September 2009
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 76 (4) , 372-382
Abstract
The neuronal ceroid lipofuscinoses (NCLs) are a family of progressive neurodegenerative diseases that are characterized by the cellular accumulation of ceroid lipofuscin‐like bodies. NCL type 1 (CLN1) and type 2 (CLN2) are caused by deficiencies of the lysosomal enzymes palmitoyl‐protein thioesterase 1 (PPT‐1) and tripeptidyl peptidase 1 (TPP‐1), respectively. In this study, 118 Latin American patients were examined for NCL using an integrated multidisciplinary program. This revealed two patients affected by CLN1 and nine by CLN2. Both CLN1 patients had a juvenile‐onset phenotype with mutation studies of one patient demonstrating the known mutation p.Arg151X and a novel mutation in intron 3, c.363‐3T>G. Six of the CLN2 patients presented with the ‘classical’ late‐infantile phenotype. The remaining three patients, who were siblings, presented with a ‘protracted’ phenotype and had a higher level of residual TPP‐1 activity than the ‘classical’ CLN2 patients. Genotype analysis of theTPP1gene in the ‘classical’ CLN2 patients showed the presence of the known mutation p.Arg208X and the novel mutations p.Leu104X, p.Asp276Val, and p.Ala453Val. The siblings with the ‘protracted’ phenotype were heterozygous for two knownTPP1mutations, p.Gln66X and c.887‐10A>G. This multidisciplinary program is also being used to diagnose other NCL types.Keywords
This publication has 23 references indexed in Scilit:
- Diagnosis of the neuronal ceroid lipofuscinoses: An updateBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteinsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Molecular genetics of the NCLs — status and perspectivesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and futureBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- The neuronal ceroid-lipofuscinoses: From past to presentBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Ser475, Glu272, Asp276, Asp327, and Asp360 are involved in catalytic activity of human tripeptidyl‐peptidase IFEBS Letters, 2005
- Rapid and Simple Assay for the Determination of Tripeptidyl Peptidase and Palmitoyl Protein Thioesterase Activities in Dried Blood SpotsClinical Chemistry, 2003
- Mutational Analysis of the Defective Protease in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis, a Neurodegenerative Lysosomal Storage DisorderThe American Journal of Human Genetics, 1999
- A Rapid Fluorogenic Palmitoyl-Protein Thioesterase Assay: Pre- and Postnatal Diagnosis of INCLMolecular Genetics and Metabolism, 1999
- Structural Organization and Sequence ofCLN2,the Defective Gene in Classical Late Infantile Neuronal Ceroid LipofuscinosisGenomics, 1998